131 related articles for article (PubMed ID: 3298908)
1. Studies on in vitro antipyrine metabolism by 13C,15N double labeled method.
Nakagawa A; Nakamura K; Maeda K; Kamataki T; Kato R
Life Sci; 1987 Jul; 41(2):133-43. PubMed ID: 3298908
[TBL] [Abstract][Full Text] [Related]
2. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
[TBL] [Abstract][Full Text] [Related]
3. Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment.
Danhof M; Krom DP; Breimer DD
Xenobiotica; 1979 Nov; 9(11):695-702. PubMed ID: 119355
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of 3-methylcholanthrene and phenobarbitone treatment on the oxidative metabolism of antipyrine in vitro by microsomal fractions of rat liver.
Kahn GC; Boobis AR; Murray S; Davies DS
Xenobiotica; 1982 Aug; 12(8):509-16. PubMed ID: 7147996
[TBL] [Abstract][Full Text] [Related]
5. Studies on the metabolism of aminopyrine, antipyrine and theophylline using monoclonal antibodies to cytochrome P-450 isozymes purified from rat liver.
Slusher LB; Park SS; Gelboin HV; Vesell ES
Biochem Pharmacol; 1987 Jul; 36(14):2359-67. PubMed ID: 2440440
[TBL] [Abstract][Full Text] [Related]
6. The effect of age on antipyrine metabolism by liver microsomes isolated from phenobarbital-treated rats.
Henderson DJ; van Bezooijen CF
Mech Ageing Dev; 1989 Sep; 49(3):287-94. PubMed ID: 2811495
[TBL] [Abstract][Full Text] [Related]
7. Identification of the human hepatic cytochromes P450 involved in the in vitro oxidation of antipyrine.
Sharer JE; Wrighton SA
Drug Metab Dispos; 1996 Apr; 24(4):487-94. PubMed ID: 8801065
[TBL] [Abstract][Full Text] [Related]
8. Aminopyrine metabolism by multiple forms of cytochrome P-450 from rat liver microsomes: simultaneous quantitation of four aminopyrine metabolites by high-performance liquid chromatography.
Imaoka S; Inoue K; Funae Y
Arch Biochem Biophys; 1988 Aug; 265(1):159-70. PubMed ID: 3415241
[TBL] [Abstract][Full Text] [Related]
9. The effect of age on the oxidative metabolism of antipyrine by uninduced microsomal fractions of rat liver.
Van Geel CA; Van Bezooijen CF
Mech Ageing Dev; 1990 Apr; 53(2):169-77. PubMed ID: 2342384
[TBL] [Abstract][Full Text] [Related]
10. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats.
van der Graaff M; Vermeulen NP; Joeres RP; Vlietstra T; Breimer DD
J Pharmacol Exp Ther; 1983 Nov; 227(2):459-65. PubMed ID: 6631725
[TBL] [Abstract][Full Text] [Related]
11. The effect of malaria infection on antipyrine metabolite formation in the rat.
Mansor SM; Ward SA; Edwards G
Biochem Pharmacol; 1991 Apr; 41(8):1264-6. PubMed ID: 2009102
[TBL] [Abstract][Full Text] [Related]
12. Effects of flumethrin on hepatic drug-metabolizing enzymes and antipyrine disposition in rats.
Anadón A; Martinez-Larrañaga MR; Diaz MJ; Bringas P; Fernandez MC; Martinez MA; Fernandez-Cruz ML
Toxicol Appl Pharmacol; 1995 May; 132(1):14-8. PubMed ID: 7747277
[TBL] [Abstract][Full Text] [Related]
13. Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on antipyrine metabolite formation in rats in vivo.
Teunissen MW; Joeres RP; Vermeulen NP; Breimer DD
Xenobiotica; 1983 Apr; 13(4):223-31. PubMed ID: 6624137
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of metronidazole and antipyrine in isolated rat hepatocytes. Influence of sex and enzyme induction and inhibition.
Loft S; Poulsen HE
Biochem Pharmacol; 1989 Apr; 38(7):1125-36. PubMed ID: 2706012
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of antipyrine, 4-hydroxyantipyrine, 3-hydroxymethylantipyrine and norantipyrine in urine by gas chromatography chemical ionization mass spectrometry.
Tang BK; Uchino H; Inaba T; Kalow W
Biomed Mass Spectrom; 1982 Oct; 9(10):425-8. PubMed ID: 7171741
[TBL] [Abstract][Full Text] [Related]
16. Highly sensitive and specific gas chromatographic-tandem mass spectrometric method for the determination of trace amounts of antipyrine metabolites in biological material.
Engel G; Hofmann U; Eichelbaum M
J Chromatogr B Biomed Appl; 1995 Apr; 666(1):111-6. PubMed ID: 7655608
[TBL] [Abstract][Full Text] [Related]
17. The effect of velnacrine on the mixed function oxidase system.
Eccles MJ; Danbury TC; Ford JM; Roberts CJ
Eur J Drug Metab Pharmacokinet; 1997; 22(2):121-5. PubMed ID: 9248779
[TBL] [Abstract][Full Text] [Related]
18. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
Szakács T; Veres Z; Vereczkey L
Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
[TBL] [Abstract][Full Text] [Related]
19. Antipyrine clearance and metabolite formation in children with congenital adrenal hyperplasia.
Teunissen MW; Bruining GJ; De Jongh BM; Tenkate-Westerhof EW; Breimer DD
Br J Clin Pharmacol; 1985 Dec; 20(6):703-6. PubMed ID: 4092001
[TBL] [Abstract][Full Text] [Related]
20. Sex difference in antipyrine 3-hydroxylation. An in vivo-in vitro correlation of antipyrine metabolism in two rat strains.
Buters JT; Reichen J
Biochem Pharmacol; 1990 Aug; 40(4):771-7. PubMed ID: 2386545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
